Atlas Trials

A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Clinical trial NCT02440685 · TERMINATED

Trial details

NCT number
NCT02440685
Sponsor
Asana BioSciences
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, FollicularCancerNeoplasmTumorLymphoma, MalignantLymphoma, B-cellLymphoma, Non-HodgkinB-Cell Chronic Lymphocytic LeukemiaB-Cell Leukemia, ChronicB-Lymphocytic Leukemia, Chronic
Start date
2015-05-01
Primary completion
2018-06-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.